Literature DB >> 8212107

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 1. A review of the epidemiology and control of malaria in The Gambia, west Africa.

B M Greenwood1, H Pickering.   

Abstract

Malaria was recognized as an important cause of death among early European visitors to The Gambia, but the infection was first studied systematically in the local population only in the 1950s. Studies undertaken in the village of Keneba at that time showed that nearly all children under the age of 5 years had parasitaemia throughout the year. More recent surveys in rural areas of The Gambia have shown much lower levels of parasitaemia, probably as a result of a decline in rainfall in The Gambia during the past 30 years and because of an increase in the availability of anti-malarial drugs. Nevertheless, community surveys and reviews of hospital statistics show that malaria is still one of the most important causes of death among Gambian children; about 1 in 25 rural Gambian children die from malaria before reaching the age of 5 years. Until recently, malaria control in The Gambia relied upon prompt treatment of clinical attacks, first with quinine and more recently with chloroquine, and upon some limited vector control in the capital, Banjul. However, during the past few years, it has been shown that mortality in rural children can be reduced substantially by means of chemoprophylaxis given by village health workers. Bed nets (mosquito nets) are used widely in The Gambia and epidemiological surveys have shown an association between the use of bed nets and protection against malaria. This observation led to a series of small scale intervention trials.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212107     DOI: 10.1016/0035-9203(93)90169-q

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  23 in total

1.  The availability of potential hosts as a determinant of feeding behaviours and malaria transmission by African mosquito populations.

Authors:  G F Killeen; F E McKenzie; B D Foy; C Bøgh; J C Beier
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Sep-Oct       Impact factor: 2.184

2.  A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children.

Authors:  Kalifa Bojang; Francis Akor; Ousman Bittaye; David Conway; Christian Bottomley; Paul Milligan; Brian Greenwood
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

3.  Transmission and cross-mating of high-level resistance Plasmodium falciparum dihydrofolate reductase haplotypes in The Gambia.

Authors:  Amani Kheir; Davis Nwakanma; Aisha Al-Gazali; Yagut Akbarova; Salma Al-Saai; Göte Swedberg; Hamza A Babiker
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

4.  Claims about the misuse of insecticide-treated mosquito nets: are these evidence-based?

Authors:  Thomas P Eisele; Julie Thwing; Joseph Keating
Journal:  PLoS Med       Date:  2011-04-12       Impact factor: 11.069

5.  Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial.

Authors:  Kalifa A Bojang; Francis Akor; Lesong Conteh; Emily Webb; Ousman Bittaye; David J Conway; Momodou Jasseh; Virginia Wiseman; Paul J Milligan; Brian Greenwood
Journal:  PLoS Med       Date:  2011-02-01       Impact factor: 11.069

6.  Thymic function and T cell parameters in a natural human experimental model of seasonal infectious diseases and nutritional burden.

Authors:  Pa T Ngom; Juan Solon; Sophie E Moore; Gareth Morgan; Andrew M Prentice; Richard Aspinall
Journal:  J Biomed Sci       Date:  2011-06-15       Impact factor: 8.410

7.  Health centre surveys as a potential tool for monitoring malaria epidemiology by area and over time.

Authors:  Abraham R Oduro; Kalifa A Bojang; David J Conway; Tumani Corrah; Brian M Greenwood; David Schellenberg
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

8.  Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.

Authors:  Domtila Kimani; Ya Jankey Jagne; Momodou Cox; Eva Kimani; Carly M Bliss; Evelyn Gitau; Caroline Ogwang; Muhammed O Afolabi; Georgina Bowyer; Katharine A Collins; Nick Edwards; Susanne H Hodgson; Christopher J A Duncan; Alexandra J Spencer; Miguel G Knight; Abdoulie Drammeh; Nicholas A Anagnostou; Eleanor Berrie; Sarah Moyle; Sarah C Gilbert; Peninah Soipei; Joseph Okebe; Stefano Colloca; Riccardo Cortese; Nicola K Viebig; Rachel Roberts; Alison M Lawrie; Alfredo Nicosia; Egeruan B Imoukhuede; Philip Bejon; Roma Chilengi; Kalifa Bojang; Katie L Flanagan; Adrian V S Hill; Britta C Urban; Katie J Ewer
Journal:  Mol Ther       Date:  2014-06-16       Impact factor: 11.454

9.  Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.

Authors:  Caroline Ogwang; Muhammed Afolabi; Domtila Kimani; Ya Jankey Jagne; Susanne H Sheehy; Carly M Bliss; Christopher J A Duncan; Katharine A Collins; Miguel A Garcia Knight; Eva Kimani; Nicholas A Anagnostou; Eleanor Berrie; Sarah Moyle; Sarah C Gilbert; Alexandra J Spencer; Peninah Soipei; Jenny Mueller; Joseph Okebe; Stefano Colloca; Riccardo Cortese; Nicola K Viebig; Rachel Roberts; Katherine Gantlett; Alison M Lawrie; Alfredo Nicosia; Egeruan B Imoukhuede; Philip Bejon; Britta C Urban; Katie L Flanagan; Katie J Ewer; Roma Chilengi; Adrian V S Hill; Kalifa Bojang
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  ANOSPEX: a stochastic, spatially explicit model for studying Anopheles metapopulation dynamics.

Authors:  Olugbenga O Oluwagbemi; Christen M Fornadel; Ezekiel F Adebiyi; Douglas E Norris; Jason L Rasgon
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.